NYSTATIN-TRIAMCINOLONE ACETONIDE Drug Patent Profile
Which patents cover Nystatin-triamcinolone Acetonide, and what generic alternatives are available?
Nystatin-triamcinolone Acetonide is a drug marketed by Pharmaderm and is included in one NDA.
The generic ingredient in NYSTATIN-TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nystatin-triamcinolone Acetonide
A generic version of NYSTATIN-TRIAMCINOLONE ACETONIDE was approved as nystatin; triamcinolone acetonide by FOUGERA PHARMS INC on October 8th, 1985.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NYSTATIN-TRIAMCINOLONE ACETONIDE?
- What are the global sales for NYSTATIN-TRIAMCINOLONE ACETONIDE?
- What is Average Wholesale Price for NYSTATIN-TRIAMCINOLONE ACETONIDE?
Summary for NYSTATIN-TRIAMCINOLONE ACETONIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| DailyMed Link: | NYSTATIN-TRIAMCINOLONE ACETONIDE at DailyMed |
US Patents and Regulatory Information for NYSTATIN-TRIAMCINOLONE ACETONIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaderm | NYSTATIN-TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 062603-001 | Oct 9, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
